Government backs scientific investigations on Kratom
The Ministry of Public Health in collaboration with the government is making preparations for human trials of a new kratom spray. This innovative development is aimed at addressing the addiction risk associated with morphine, while offering an alternative for treating severe pain, particularly muscle pain.
The kratom spray, currently in the research phase, has seen significant improvements in its purity. The extracted mitragynine, a crucial indole-based alkaloid found in kratom plants, now boasts a purity level of 99.9%.
The government's support for kratom research extends beyond the kratom spray. It also includes the development of oral medicines for cancer patients, with the aim of expanding kratom research further.
Animal and cell culture studies have shown promising results for the kratom spray, suggesting it could be an effective solution for pain relief and inflammation. The primary purpose of the spray is to alleviate muscle pain, making it a potential game-changer in the field of pain management.
The human trials for the kratom spray are scheduled to commence in the middle of next year. If successful, this could pave the way for a new era in pain management and addiction treatment. The government's commitment to supporting this research project underscores its dedication to improving healthcare and quality of life for its citizens.
Read also:
- Peptide YY (PYY): Exploring its Role in Appetite Suppression, Intestinal Health, and Cognitive Links
- Toddler Health: Rotavirus Signs, Origins, and Potential Complications
- Digestive issues and heart discomfort: Root causes and associated health conditions
- House Infernos: Deadly Hazards Surpassing the Flames
